在当代无关血细胞移植中HLA不匹配的风景
Esteban Arrieta-Bolaños1,2, Edouard F Bonneville3,4, Pietro Crivello1
1Institute for Experimental Cellular Therapy, University Hospital Essen, Essen, Germany.
HLA
|March 11, 2026
概括
使用HLA不匹配的非相关捐赠者 (MMUD) 进行血造细胞移植 (HCT) 对缺乏匹配捐赠者的患者至关重要. 这项研究分析了28376例移植中的HLA匹配,揭示了不匹配频率及其对捐赠者选择和风险评估的影响.
科学领域:
- 免疫遗传学 免疫遗传学
- 移植免疫学 移植免疫学
背景情况:
- 用HLA不匹配的非相关捐赠体 (MMUD) 进行血造细胞移植 (HCT) 扩大了没有合适的HLA匹配捐赠体的患者获得治愈治疗的机会.
- 功能匹配,除了简单的等位基因匹配之外,越来越被认为是成功的HCT结果的关键.
研究的目的:
- 描述现实世界的HLA不匹配频率在一个大队列的无关的捐赠者HCT接受者.
- 为评估患者风险和优化MMUD-HCT中供体选择策略提供数据.
主要方法:
- 分析了EBMT注册表中的28,376个第一个无关的HCT,使用6位点高分辨率的HLA类型.
- 在等位基,抗原基和功能水平上对HLA不匹配的量化和表征.
- 移植时代的不匹配频率的比较以及移植后环胺 (PTCy) 和非PTCy疗法之间的比较.
主要成果:
- 25%的移植有一个或多个高分辨率的HLA不匹配,增加到43.9%的PTCy.
- 从诊断到移植的中位时间随着时间的推移而减少MMUD-HCT.
- 与I类相比,II类不匹配显示出更高的功能匹配频率,这是由于对等位基分布的偏差造成的.
结论:
- 这项研究提供了对当代无关HCT中HLA不匹配频率的首次大规模表征.
- 这些发现对临床结果研究和完善MMUD-HCT中供体选择标准有重大影响.
- 了解功能匹配是改善HLA不匹配移植结果的关键.
相关概念视频
Tissue Transplantation
1.1K
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.1K
Bone Marrow Sampling and Transplants
2.1K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.1K
Multipotency of Hematopoietic Stem Cells
4.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
4.1K
Mismatch Repair
6.9K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
6.9K
Cell-mediated Immune Responses
85.6K
Overview
85.6K
Regulation of Hematopoietic Stem Cells
4.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.3K


